Hamilton Wealth’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
CI
JSAM
AT
MIM
Hamilton Wealth's PPH Position: Q3 2025 in Review
Hamilton Wealth sold out of VanEck Pharmaceutical ETF (PPH) in Q3 2025, closing a stake of 132,463 shares — an estimated $11.7M sold.
Hamilton Wealth first reported a position in PPH in Q4 2024 and held it in 3 quarters. The position peaked at $11.7M in Q2 2025. 127 funds tracked by Wall St. Rank hold PPH as of Q3 2025.
- Hamilton Wealth reported no remaining VanEck Pharmaceutical ETF position as of Q3 2025 after selling out during the quarter.
- Hamilton Wealth sold 132,463 VanEck Pharmaceutical ETF shares in Q3 2025, an estimated $11.7M.
- Hamilton Wealth first reported a position in VanEck Pharmaceutical ETF in Q4 2024 and held it in 3 quarters.
- Hamilton Wealth's VanEck Pharmaceutical ETF position peaked at $11.7M in Q2 2025.
- 127 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2025.
Based on Hamilton Wealth's 13F filing for Q3 2025, filed 14 Nov 2025.